InMode IPO on Aug. 8

Cindy Kellogue of the Mayfield Reporter reported that InMode Ltd. (INMD) is planning to raise $75 million in an initial public offering on Thursday, August 8th, IPO Scoop reports. The company will be issuing 5,000,000 shares at a price of $14.00-$16.00 per share.

In the last 12 months, InMode Ltd. generated $109.8 million in revenue and $26.1 million in net income. InMode Ltd. has a market cap of $479.6 million.

Barclays, UBS Investment Bank and Canaccord Genuity served as the underwriters for the IPO and Baird was co-manager.

InMode Ltd. provided the following description of their company for its IPO: ” We are a leading global provider of innovative, energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. Within the global aesthetics market, our products and solutions are primarily designed to address three energy-based treatment categories comprised of: (i) face and body contouring; (ii) medical aesthetics; and (iii) women’s health. We have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. “.

InMode Ltd. was founded in 2008 and has 209 employees. The company is located at Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel and can be reached via phone at +972-4-9096313 or on the web at http://www.inmodemd.com.